Cargando…

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19

Detalles Bibliográficos
Autores principales:	Salmanton-García, Jon, Busca, Alessandro, Cornely, Oliver A., Corradini, Paolo, Hoenigl, Martin, Klimko, Nikolai, Marchesi, Francesco, Pagliuca, Antonio, Passamonti, Francesco, Koehler, Philipp, Pagano, Livio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232068/ https://www.ncbi.nlm.nih.gov/pubmed/34235404 http://dx.doi.org/10.1097/HS9.0000000000000612

Ejemplares similares

P1607: EPICOVIDEHA KIDS: A READY TO USE PLATFORM FOR EPIDEMIOLOGICAL STUDIES IN PEDIATRIC HEMATOLOGICAL PATIENTS WITH COVID-19
por: Salmanton-García, J., et al.
Publicado: (2022)

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)
por: Marchesi, Francesco, et al.
Publicado: (2021)

Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients
por: Salmanton-García, Jon, et al.
Publicado: (2023)

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
por: Pagano, Livio, et al.
Publicado: (2022)

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
por: Busca, Alessandro, et al.
Publicado: (2022)

COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey
por: Lamure, Sylvain, et al.
Publicado: (2022)

P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
por: Salmanton-García, Jon, et al.
Publicado: (2023)

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
por: Pagano, Livio, et al.
Publicado: (2022)

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
por: Salmanton-García, Jon, et al.
Publicado: (2022)

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
por: Pagano, Livio, et al.
Publicado: (2021)

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
por: Marchesi, Francesco, et al.
Publicado: (2022)

P55 MULTIPLE MYELOMA AND SARS-COV-2 INFECTION: AN EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA) OF 1,221 PATIENTS THROUGH THE DIFFERENT PHASES OF COVID-19 PANDEMIC
por: Musto, P., et al.
Publicado: (2023)

P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT
por: Salmanton-García, Jon, et al.
Publicado: (2023)

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
por: Marchesi, Francesco, et al.
Publicado: (2023)

Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
por: Blennow, Ola, et al.
Publicado: (2022)

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
por: Infante, Maria Stefania, et al.
Publicado: (2022)

Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
por: Cattaneo, Chiara, et al.
Publicado: (2022)

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
por: Busca, Alessandro, et al.
Publicado: (2023)

Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
por: Marchetti, Monia, et al.
Publicado: (2023)

When Viruses Meet Fungi: Tackling the Enemies in Hematology
por: Busca, Alessandro, et al.
Publicado: (2022)

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
por: Salmanton-García, Jon, et al.
Publicado: (2023)

S292: NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY
por: Salmanton-García, Jon, et al.
Publicado: (2023)

PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY
por: Buquicchio, Caterina, et al.
Publicado: (2023)

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
por: van Doesum, Jaap A., et al.
Publicado: (2023)

753. Guideline Adherence Predicts Outcomes of Candidemia in Europe: Results from the ECMM Candida III Multinational European study
por: Hoenigl, Martin, et al.
Publicado: (2022)

618. The current state of laboratory mycology in Asia/Pacific: a survey from the EuropeanConfederation of Medical Mycology (ECMM) and International Society for Human andAnimal Mycology (ISHAM)
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

617. Laboratory capacities to diagnose and treat Invasive Fungal Infections in Europe: results from an ECMM survey
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn)
por: Salmanton-Garcia, Jon, et al.
Publicado: (2019)

Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

2046. FungiScope™: News on the Global Emerging Fungal Infection Registry
por: Seidel, Danila, et al.
Publicado: (2018)

Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review
por: Shadrivova, Olga V., et al.
Publicado: (2019)

1172. Mucormycosis Treated with Isavuconazole: A matched-Pair Analysis from the FungiScope(®) Registry
por: Seidel, Danila, et al.
Publicado: (2020)

From words to pixels: The Infectious Diseases in Motion (IDIM) and VACCELERATE experience for fast and accessible science audiovisual communication
por: Salmanton-García, Jon, et al.
Publicado: (2023)

Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents
por: Livio, Pagano, et al.
Publicado: (2018)

Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(®) registry
por: Sal, Ertan, et al.
Publicado: (2022)

Antifungal Therapy in Hematopoietic Stem Cell Transplant Recipients
por: Busca, Alessandro, et al.
Publicado: (2016)

Monkeypox diagnostic and treatment capacity at epidemic onset: A VACCELERATE online survey
por: Grothe, Jan Hendrik, et al.
Publicado: (2022)

Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey
por: Grothe, Jan Hendrik, et al.
Publicado: (2023)

Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey
por: Grothe, Jan Hendrik, et al.
Publicado: (2023)

Viral infections in patients with hematological malignancies
por: Busca, A
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_se2e4h8na2do56uf74d4ldabhi